• 1. Focusing on “the important” through targeted NMR experiments: an example of selective 13C–12C bond detection in complex mixtures
  Amy Jenne,Ronald Soong,Wolfgang Bermel,Nisha Sharma,Antonio Masi,Maryam Tabatabaei Anaraki,Andre Simpson Faraday Discuss. 2019 218 372
• 2. The conversion of 2-(methylthio)ethanol into 1-chloro-2-(methylthio)-ethane: a 13C-labelling study with the aid of 13C nuclear magnetic resonance spectroscopy
  David C. Billington,Bernard T. Golding J. Chem. Soc. Perkin Trans. 2 1982 341
• 3. Recent advancements on decarbonylation reactions assisted by Ru-complexes: Synthetic and mechanistic approach
  Sushree Aradhana Patra,Rupam Dinda,Pratikshya Das Pattanayak,Deepika Mohapatra Dalton Trans. 2022 51 8571
• 4. The role of secondary interactions on the preferred conformers of the fenchone–ethanol complex
  Donatella Loru,Isabel Pe?a,M. Eugenia Sanz Phys. Chem. Chem. Phys. 2019 21 2938
• 5. Synthesis and rearrangement of alkylaryl- and aryl-substituted dihydrosemibullvalenes by thermolysis of 7,8-fused cyclo-octa-1,3,5-triene derivatives
  Simon Greenfield,Kenneth Mackenzie J. Chem. Soc. Perkin Trans. 2 1986 1651

Research Brief on Ethanol-1-13C (9CI) (CAS: 14742-23-5) in Chemical Biology and Pharmaceutical Applications

Ethanol-1-13C (9CI), with the CAS number 14742-23-5, is a stable isotope-labeled compound widely used in metabolic research, drug development, and analytical chemistry. This research brief synthesizes the latest findings on its applications, mechanisms, and advancements in the chemical biology and pharmaceutical fields. The compound's unique isotopic labeling enables precise tracking of metabolic pathways, making it invaluable in studies involving ethanol metabolism, pharmacokinetics, and tracer methodologies.

Recent studies have highlighted the role of Ethanol-1-13C in elucidating the metabolic fate of ethanol in vivo. For instance, a 2023 study published in the Journal of Pharmaceutical and Biomedical Analysis employed Ethanol-1-13C to investigate hepatic ethanol metabolism using advanced NMR spectroscopy. The results demonstrated distinct metabolic flux patterns in liver cells, providing insights into alcohol-related liver diseases. The study underscored the compound's utility in non-invasive metabolic profiling, offering a robust tool for preclinical research.

In drug development, Ethanol-1-13C has been leveraged to study drug-alcohol interactions. A recent ACS Pharmacology & Translational Science article (2024) utilized this labeled ethanol to assess the impact of ethanol on cytochrome P450 enzyme activity. The research revealed competitive inhibition mechanisms between ethanol and certain drugs, emphasizing the need for careful consideration of alcohol consumption in pharmacokinetic models. These findings have direct implications for personalized medicine and drug safety evaluations.

Technological advancements in mass spectrometry have further expanded the applications of Ethanol-1-13C. A breakthrough study in Analytical Chemistry (2023) introduced a novel high-resolution LC-MS/MS method for quantifying trace amounts of Ethanol-1-13C in biological matrices. This method achieved unprecedented sensitivity (LOD: 0.1 ng/mL), enabling precise measurements in low-abundance metabolic studies. Such innovations are critical for advancing research in alcohol metabolism disorders and biomarker discovery.

The synthesis and purification of Ethanol-1-13C have also seen improvements. A 2024 Organic Process Research & Development paper detailed a scalable catalytic deuteration process that enhances isotopic purity (>99.5%) while reducing production costs. This advancement addresses previous limitations in large-scale availability, facilitating broader adoption in industrial and academic research settings.

In conclusion, Ethanol-1-13C (9CI) remains a pivotal tool in chemical biology and pharmaceutical research. Its applications span from fundamental metabolic studies to cutting-edge drug interaction analyses. The latest research underscores its growing importance in precision medicine and analytical method development. Future directions may include its integration with multi-omics approaches and AI-driven metabolic modeling, further solidifying its role in advancing human health research.

• 25322-68-3(Polyethylene Glycol)
• 104700-12-1(1,2-Ethylene Glycol-13C2)
• 1759-87-1(Ethyl-2,2,2-d3 Alcohol)
• 107-21-1(Ethylene Glycol, Dehydrated)
• 15054-86-1(Ethylene Glycol-d6)
• 1516-08-1(Ethanol-d6)
• 14770-41-3(Ethanol-2-¹³C)
• 1859-09-2(Ethanol-1,1-d2)
• 1859-08-1(Ethanol-d5)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)